Calidi Biotherapeutics, Inc. (CLDI) financial statements and ratios from SEC XBRL: revenue $45000.00 (TTM), net margin 7844.9%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $45000.00 |
| Net Margin | 7844.9% |
| Price / Book | 1.09 |
| Sector P/E (Healthcare) | 21.7 |
CLDI overview · CLDI earnings · CLDI KPIs · CLDI investor relations · CLDI ownership · CLDI peers · CLDI filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.